Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
Authors
Keywords
Extracellular matrix, Hyaluronan, Chemotherapy, ABC transporters, Ovarian cancer
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-10-14
DOI
10.1186/1471-2407-13-476
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma
- (2012) S. J. Lee et al. CLINICAL CANCER RESEARCH
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- The role of ATP-binding cassette transporters in bacterial pathogenicity
- (2012) Victoria G. Lewis et al. PROTOPLASMA
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Improving Cancer Chemotherapy with Modulators of ABC Drug Transporters
- (2011) S. Shukla et al. CURRENT DRUG TARGETS
- Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
- (2011) Miranda Ween et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma
- (2011) Z Qin et al. LEUKEMIA
- Reduction of Hyaluronan-CD44–Mediated Growth, Migration, and Cisplatin Resistance in Head and Neck Cancer Due to Inhibition of Rho Kinase and PI-3 Kinase Signaling
- (2010) Carlos Torre et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides
- (2010) Miranda P. Ween et al. CLINICAL & EXPERIMENTAL METASTASIS
- Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells
- (2010) Miranda P. Ween et al. INTERNATIONAL JOURNAL OF CANCER
- Proinflammatory Cytokines Induce Hyaluronan Synthesis and Monocyte Adhesion in Human Endothelial Cells through Hyaluronan Synthase 2 (HAS2) and the Nuclear Factor-κB (NF-κB) Pathway
- (2010) Davide Vigetti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin
- (2009) Giovanni Luca Beretta et al. BIOCHEMICAL PHARMACOLOGY
- Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression
- (2009) H Chen et al. BRITISH JOURNAL OF CANCER
- Abrogating Drug Resistance in Malignant Peripheral Nerve Sheath Tumors by Disrupting Hyaluronan-CD44 Interactions with Small Hyaluronan Oligosaccharides
- (2009) M. G. Slomiany et al. CANCER RESEARCH
- Hyaluronan substratum induces multidrug resistance in human mesenchymal stem cells via CD44 signaling
- (2009) Chi-Mou Liu et al. CELL AND TISSUE RESEARCH
- ABC transporter gene expression in benign and malignant ovarian tissue
- (2009) Veronika Auner et al. GYNECOLOGIC ONCOLOGY
- Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis
- (2009) Areeg Faggad et al. HISTOPATHOLOGY
- Inhibition of multi-drug resistance of ovarian carcinoma by small interfering RNA targeting to MRP2 gene
- (2008) Jia-jia Ma et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Targeting Hyaluronan Interactions in Malignant Gliomas and Their Drug-Resistant Multipotent Progenitors
- (2008) A. G. Gilg et al. CLINICAL CANCER RESEARCH
- A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent In vivo Therapeutic Activity
- (2008) A. Banzato et al. CLINICAL CANCER RESEARCH
- Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
- (2008) Bryan P. Toole et al. DRUG RESISTANCE UPDATES
- Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates β-Catenin Signaling and NFκB-specific Transcription Activity Leading to MDR1 and Bcl-xLGene Expression and Chemoresistance in Breast Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression
- (2008) Lilly Y.W. Bourguignon SEMINARS IN CANCER BIOLOGY
- Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer
- (2007) Duygu Derin et al. LUNG CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now